Thirty eyes of @ patients with BRVO of at least @ weeks duration were randomized into three groups : Group @ received a single dose of intravitreal Ranibizumab followed by grid laser treatment , Group @ received a single dose of intravitreal Bevacizumab followed by grid laser treatment , and Group @ received grid laser alone .